| Molecular formula | C50H69N15O9 |
|---|
| Molecular weight | 1024.2 g/mol |
|---|
| Registered trials | 1 |
|---|
| PubChem CID | 92432 |
|---|
What melanotan II is
Melanotan II is a synthetic peptide compound (molecular formula C50H69N15O9) cataloged under PubChem CID 92432. It has no FDA-approved label, no approved brand name, and no established indication for human use. Any use outside of a registered clinical trial falls outside regulatory oversight.
Trial footprint
One trial involving melanotan II is currently registered. That study, NCT07437560, is recruiting participants to evaluate melanotan II as an adjunct to NB-UVB phototherapy for repigmentation in stable nonsegmental vitiligo, listed at Phase 2. Beyond this single registered trial, there is no broader public trial record available for this compound.
FAQ
No. Melanotan II has no FDA-approved label, brand name, or approved indication. It remains classified as an unapproved research compound.
The one registered trial is examining melanotan II as an add-on to NB-UVB phototherapy for repigmentation in people with stable nonsegmental vitiligo. This trial is currently recruiting and at an early phase of investigation.
Public records show one registered clinical trial for melanotan II as of the latest data retrieval. This limited footprint means the compound's effects in humans are not yet well characterized.
Melanotan II is a synthetic peptide with the molecular formula C50H69N15O9 and a molecular weight of approximately 1024.2. It is cataloged in PubChem under CID 92432.
No adverse event report data is currently available for melanotan II in the sources reviewed here. The absence of reported data does not mean the compound is free of risk.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 92432 ClinicalTrials.gov NCT07437560
Updated 2026-11-07